This two-day awareness session for international regulators , academia and non-governmental organisations gave an insight into how the European medicines regulatory network works, the role of European Medicines Agency (EMA), scientific aspects of EMA’s work and its interaction with scientific experts. It addressed topics including the role of experts and benefit-risk evaluation.
